Taking the sickle cell drug hydroxyurea during or shortly before pregnancy does not appear to cause specific issues in newborns, according to the first prospective study of pregnancies involving ...
Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital ...
SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...
Machine learning identified RDW and HGB as key predictors of hydroxyurea resistance in polycythemia vera, aiding early identification and treatment adjustment. The PV-AIM study used electronic health ...
Hydroxyurea does not significantly reduce ovarian reserve in girls and women with sickle cell disease. Fertility preservation measures before hydroxyurea treatment may not be necessary. The study ...
Researchers have identified an alternate method to study changes during the DNA replication process in lab settings using genetically modified yeast. The new approach offers a clearer window than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results